Merck & Company Inc (MRK)vsWarby Parker Inc (WRBY)
MRK
Merck & Company Inc
$120.79
-3.46%
HEALTHCARE · Cap: $285.64B
WRBY
Warby Parker Inc
$22.72
-5.80%
HEALTHCARE · Cap: $3.04B
Smart Verdict
WallStSmart Research — data-driven comparison
Merck & Company Inc generates 7285% more annual revenue ($65.77B vs $890.57M). MRK leads profitability with a 13.6% profit margin vs 0.1%. MRK trades at a lower P/E of 32.6x. MRK earns a higher WallStSmart Score of 50/100 (D+).
MRK
Hold50
out of 100
Grade: D+
WRBY
Avoid31
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-49.3%
Fair Value
$80.88
Current Price
$120.79
$39.91 premium
Margin of Safety
-50.4%
Fair Value
$14.62
Current Price
$22.72
$8.10 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Strong operational efficiency at 38.6%
Generating 2.9B in free cash flow
No standout strengths identified
Areas to Watch
Premium valuation, high expectations priced in
4.9% revenue growth
Elevated debt levels
Weak financial health signals
ROE of 0.4% — below average capital efficiency
0.1% margin — thin
Operating margin of 0.9%
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : MRK
The strongest argument for MRK centers on Market Cap, Operating Margin, Free Cash Flow.
Bull Case : WRBY
WRBY has a balanced fundamental profile.
Bear Case : MRK
The primary concerns for MRK are P/E Ratio, Revenue Growth, Debt/Equity.
Bear Case : WRBY
The primary concerns for WRBY are Return on Equity, Profit Margin, Operating Margin. A P/E of 2479.0x leaves little room for execution misses. Thin 0.1% margins leave little buffer for downturns.
Key Dynamics to Monitor
WRBY carries more volatility with a beta of 1.96 — expect wider price swings.
WRBY is growing revenue faster at 8.3% — sustainability is the question.
MRK generates stronger free cash flow (2.9B), providing more financial flexibility.
Monitor DRUG MANUFACTURERS - GENERAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
MRK scores higher overall (50/100 vs 31/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Merck & Company Inc
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
Visit Website →Warby Parker Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Warby Parker Inc. (WRBY) is a trendsetting leader in the direct-to-consumer eyewear market, established in 2010 with the mission to revolutionize the way consumers purchase eyewear through a seamless blend of online shopping and an expanding number of retail stores. The company is renowned for its stylish, affordable prescription glasses and sunglasses, appealing to a broad range of customers. Warby Parker's socially conscious business model, epitomized by its "Buy a Pair, Give a Pair" initiative, reflects a commitment to social responsibility by providing eyewear to those in need. With a robust brand reputation and a dedication to innovative marketing strategies, Warby Parker is well-positioned for ongoing growth and success in a competitive landscape.
Visit Website →Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?